ImportRefusal LogoImportRefusal

Novetide Ltd.

⚠️ Moderate Risk

FEI: 3002807897 • Netanya • ISRAEL

FEI

FEI Number

3002807897

📍

Location

Netanya

🇮🇱

Country

ISRAEL
🏢

Address

1, HaPlada, Industrial Zone, , Netanya, , Israel

Moderate Risk

FDA Import Risk Assessment

39.5
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

7
Total Refusals
3
Unique Violations
7/13/2009
Latest Refusal
9/17/2004
Earliest Refusal

Score Breakdown

Violation Severity
70.0×40%
Refusal Volume
33.5×30%
Recency
0.0×20%
Frequency
14.5×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

165×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
7/13/2009
60LCS14CARBAMAZEPINE (ANALGESIC)
16DIRECTIONS
New York District Office (NYK-DO)
7/13/2009
61NCS03AMITRIPTYLINE HCL (ANTI-DEPRESSANT)
16DIRECTIONS
New York District Office (NYK-DO)
4/22/2009
61NCS03AMITRIPTYLINE HCL (ANTI-DEPRESSANT)
16DIRECTIONS
Minneapolis District Office (MIN-DO)
11/18/2004
61NCS03AMITRIPTYLINE HCL (ANTI-DEPRESSANT)
16DIRECTIONS
New York District Office (NYK-DO)
9/29/2004
61HCZ03TRIMETHOPRIM (ANTI-BACTERIAL)
75UNAPPROVED
New York District Office (NYK-DO)
9/24/2004
61NCZ03AMITRIPTYLINE HCL (ANTI-DEPRESSANT)
16DIRECTIONS
New York District Office (NYK-DO)
9/17/2004
61JCZ11GEMFIBROZIL (ANTI-CHOLESTEREMIC)
118NOT LISTED
New York District Office (NYK-DO)

Frequently Asked Questions

What is Novetide Ltd.'s FDA import refusal history?

Novetide Ltd. (FEI: 3002807897) has 7 FDA import refusal record(s) in our database, spanning from 9/17/2004 to 7/13/2009.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Novetide Ltd.'s FEI number is 3002807897.

What types of violations has Novetide Ltd. received?

Novetide Ltd. has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Novetide Ltd. come from?

All FDA import refusal data for Novetide Ltd. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.